JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹26 Cr | ₹18 Cr | ₹8.49 Cr | ₹4.49 Cr | ₹1.88 Cr |
What is the latest Total Non-Current Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹8.49 Cr |
| Mar2022 | ₹4.49 Cr |
| Mar2021 | ₹1.88 Cr |
How is Total Non-Current Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 43.46 | |
| Mar2024 | ₹18 Cr | 113.41 | |
| Mar2023 | ₹8.49 Cr | 88.81 | |
| Mar2022 | ₹4.49 Cr | 139.42 | |
| Mar2021 | ₹1.88 Cr | - | |
Compare Total Non-Current Liabilities of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,172.8 Cr | 1.1% | 6.3% | -24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | 1.1% |
6.3% |
-24.4% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses